![](https://www.diabetesnews.com/wp-content/uploads/2012/05/fda_logo_pills-150x150.jpg)
Also known as dulaglutide, Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps normalize blood sugar levels by encouraging the release of insulin, which helps the body better use available blood glucose, while suppressing the stimulation of glucose production.